Soligenix (SNGX) Non-cash Items (2010 - 2020)
Soligenix's (SNGX) quarterly Non-cash Items came in at -$1.2 million in Q3 2020, down 281.15% YoY from $662867.0 in Q4 2019, and down 205.95% on a QoQ basis from $1.1 million in Q2 2020.
Soligenix (SNGX) Non-cash Items (2010 - 2020) Analysis & Trends
Soligenix (SNGX) has 11 years of Non-cash Items data on file, last reported at -$1.2 million in Q3 2020.
- Quarterly Non-cash Items fell 281.15% year-over-year to -$1.2 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $5.0 million (up 146.59% YoY) and the FY2019 annual result came in at $1.8 million, up 11.52% from the prior year.
- Non-cash Items eased to -$1.2 million in Q3 2020, from $1.1 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $4.9 million in Q1 2020 to a low of -$1.6 million in Q2 2016.
- A 5-year average of $379980.7 and a median of $429115.0 in 2018 frame the typical range for Non-cash Items.
- The widest YoY moves for Non-cash Items: up 847.51% in 2020, down 281.15% in 2020.
- Tracing SNGX's Non-cash Items over 5 years: stood at -$1.1 million in 2016, then surged by 83.63% to -$179309.0 in 2017, then jumped by 339.32% to $429115.0 in 2018, then slumped by 46.78% to $228382.0 in 2019, then plunged by 625.78% to -$1.2 million in 2020.
- The last three Non-cash Items figures came in at -$1.2 million (Q3 2020), $1.1 million (Q2 2020), and $4.9 million (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -1.20 Mn |
| Sep 30, 2020 | -1.20 Mn |
| Jun 30, 2020 | 1.13 Mn |
| Jun 30, 2020 | 1.13 Mn |
| Mar 31, 2020 | 4.89 Mn |
| Mar 31, 2020 | 4.89 Mn |
| Dec 31, 2019 | 228,382.00 |
| Dec 31, 2019 | 228,382.00 |
| Sep 30, 2019 | 662,867.00 |
| Sep 30, 2019 | 662,867.00 |
| Jun 30, 2019 | 1.61 Mn |
| Jun 30, 2019 | 1.61 Mn |
| Mar 31, 2019 | -653,676.00 |
| Mar 31, 2019 | -653,676.00 |
| Dec 31, 2018 | 429,115.00 |
| Dec 31, 2018 | 429,115.00 |
| Sep 30, 2018 | 893,773.00 |
| Sep 30, 2018 | 893,773.00 |
| Jun 30, 2018 | -585,444.00 |
| Jun 30, 2018 | -585,444.00 |